Literature DB >> 23833936

[Mechanism about therapeutic effect of meisoindigo on psoriasis via down-regulation of the TLR4-TAK-NF-kappaB pathways].

Hai-Jing Zhang1, Yi Zhang, Jing Jin, Wan-Qi Zhou, Xiao-Guang Chen.   

Abstract

Meisoindigo is an indigo natural derivative commonly used in anti-cancer therapy. In the clinical application, it was also found to have good therapeutic effect on psoriasis. In order to further understand its mechanism of action, human normal keratinocyte cell line HaCaT and RAW 264.7 were used to identify if meisoindigo could affect the inflammatory factors such as NO and other important cytokines which were highly involved in psoriasis. Our results indicated that meisoindigo decreased the production of NO in LPS-stimulated RAW 264.7 cells and reduced the expression of cytokines in LPS-stimulated HaCaT cells. And TLR4-TAK-NF-kappaB was a possible pathway mainly involved in the attenuation of iNOS and pro-inflammatory cytokine production by meisoindigo, which may take part in the therapeutic effect of meisoindigo on psoriasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23833936

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  2 in total

1.  Meisoindigo, but not its core chemical structure indirubin, inhibits zebrafish interstitial leukocyte chemotactic migration.

Authors:  Baixin Ye; Xiaoxing Xiong; Xu Deng; Lijuan Gu; Qiongyu Wang; Zhi Zeng; Xiang Gao; Qingping Gao; Yueying Wang
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

2.  Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway.

Authors:  Yingze Ye; Tong Jin; Xu Zhang; Zhi Zeng; Baixin Ye; Jinchen Wang; Yi Zhong; Xiaoxing Xiong; Lijuan Gu
Journal:  Front Cell Neurosci       Date:  2019-12-16       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.